APA (7th ed.) Citation

Yamanishi, Y., Choudhury, M. E., Yoshida, A., Hosokawa, Y., Miyaue, N., Tada, S., . . . Nagai, M. (2022). Impact of Intestinal Bacteria on Levodopa Pharmacokinetics in LCIG Therapy. Movement Disorders Clinical Practice, 9(3), 362. https://doi.org/10.1002/mdc3.13417

Chicago Style (17th ed.) Citation

Yamanishi, Yuki, et al. "Impact of Intestinal Bacteria on Levodopa Pharmacokinetics in LCIG Therapy." Movement Disorders Clinical Practice 9, no. 3 (2022): 362. https://doi.org/10.1002/mdc3.13417.

MLA (9th ed.) Citation

Yamanishi, Yuki, et al. "Impact of Intestinal Bacteria on Levodopa Pharmacokinetics in LCIG Therapy." Movement Disorders Clinical Practice, vol. 9, no. 3, 2022, p. 362, https://doi.org/10.1002/mdc3.13417.